Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
Effect of a Medicated Topical Therapy, Petrolatum, and No Treatment on Nocturnal Cough and Congestion for Children With Upper Respiratory Infections
1 other identifier
interventional
143
1 country
1
Brief Summary
This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2008
CompletedFirst Posted
Study publicly available on registry
August 29, 2008
CompletedStudy Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedNovember 24, 2017
November 1, 2017
1.4 years
August 28, 2008
November 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective assessment of cough and congestion symptoms
24 hours
Study Arms (3)
A
ACTIVE COMPARATORB
PLACEBO COMPARATOR3
NO INTERVENTIONno intervention
Interventions
Eligibility Criteria
You may qualify if:
- Cough and congestion attributed to upper respiratory tract infection
You may not qualify if:
- Children with signs or symptoms of more serious or treatable disease
- Presence of itchy, watery eyes or frequent sneezing
- Tachypnea (respiratory rate \>95%ile) or labored breathing
- Symptoms for 8 or more days
- History of asthma in the past 2 years, chronic lung disease, or seizure disorder
- History of an allergic reaction to camphor, menthol, eucalyptus, petrolatum, cedarleaf oil, nutmeg oil, thymol, turpentine oil, Over-the-counter medication containing VVR components
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Penn State Universitylead
- Procter and Gamblecollaborator
Study Sites (1)
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033-0850, United States
Related Publications (1)
Paul IM, Beiler JS, King TS, Clapp ER, Vallati J, Berlin CM Jr. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics. 2010 Dec;126(6):1092-9. doi: 10.1542/peds.2010-1601. Epub 2010 Nov 8.
PMID: 21059712DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ian M Paul, MD, MSc
Penn State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2008
First Posted
August 29, 2008
Study Start
October 1, 2008
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
November 24, 2017
Record last verified: 2017-11